Abbott FreeStyle InsuLinx Owner's Booklet page 44

References:
1 "FDA Public Health Notification: Use of Fingerstick Devices on More than One Person Poses Risk for Transmitting
Bloodborne Pathogens: Initial Communication" (2010) http://www.fda.gov/MedicalDevices/Safety/
AlertsandNotices/ucm224025.htm
"CDC Clinical Reminder: Use of Fingerstick Devices on More than One Person Poses Risk for Transmitting
2
Bloodborne Pathogens" (2010) http://www.cdc.gov/injectionsafety/Fingerstick-DevicesBGM.html
3 Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF
consultation. World Health Organization, Geneva, Switzerland 2006.
Product Inserts: HumaLog®, NovoLog®, Apidra®
4
5 Diabetes Care. January 2010, vol. 33, no. Supplement 1, S11-S61.
Hirsch, I. (2005). Glycemic Variability: It's Not Just About A1C Anymore! Diabetes Technology and Therapeutics,
6
7 (5), 780-783.
7 Mayo Clinic Proceedings February 2007, vol. 82, no. 2, 229-236.
Pearson J, Bergenstal R. Fine-Tuning Control: Pattern Management Versus Supplementation: View 1: Pattern
8
Management: an Essential Component of Effective Insulin Management. Diabetes Spectr. April 1, 2001;
14(2)75-78.
81